Is this your brand? Sign in to claim ownership.

Sign in to claim this brand

Firstkind, Ltd.

US

Last updated May 30, 2026

Part of Firstkind Limited

What Firstkind, Ltd. makes

Firstkind, Ltd. manufactures transcutaneous neuromuscular electrical stimulation (TENS/NMES) systems designed for physical therapy, including portable and modular devices for muscle stimulation and rehabilitation. Their portfolio includes handheld units like the geko series, a wearable firefly device, and advanced models such as the geko T-2 and geko Plus R-2, which offer adjustable stimulation parameters for targeted muscle activation.

These devices are classified as Class II under FDA regulations and are authorised via 510(k) premarket notifications and UDI (Unique Device Identification) compliance. The company’s products are listed in the FDA’s regulatory databases, and the manufacturer is based in the United States.

Written from this company's registered devices by an AI model, and not verified by a human reviewer.

Frequently asked questions

What types of medical devices does Firstkind, Ltd. manufacture?

Firstkind, Ltd. specializes in transcutaneous neuromuscular electrical stimulation (TENS/NMES) systems primarily used in physical therapy. Their devices are designed to stimulate muscles and aid rehabilitation, including portable handheld units like the geko series and wearable devices such as the firefly. These systems are engineered to deliver targeted muscle activation through adjustable electrical stimulation parameters.

Where is Firstkind, Ltd. based, and what regulatory databases list their devices?

Firstkind, Ltd. is headquartered in the United States. Their devices are authorised under FDA regulations and appear in the FDA’s regulatory databases, including the 510(k) premarket notification listings and the Unique Device Identification (UDI) system. This ensures compliance with U.S. medical device regulations.

How are Firstkind, Ltd.’s devices classified under FDA regulations?

Firstkind, Ltd.’s neuromuscular electrical stimulation systems fall under Class II classification by the FDA. This classification is typically assigned to devices that pose moderate risk and require special controls to ensure safety and effectiveness, such as premarket notifications (510(k)) and compliance with UDI requirements.

What is the purpose of Firstkind, Ltd.’s geko and firefly devices?

The geko series and firefly devices are designed for physical therapy applications, delivering transcutaneous neuromuscular electrical stimulation (TENS/NMES) to promote muscle activation, rehabilitation, and pain management. The geko models are handheld and portable, while the firefly is a wearable device, offering flexibility in clinical and home-use settings.

AI-generated from registry data and not verified by a human reviewer.

Information

Country
US
Address
—
LinkedIn
—
Facebook
—
Phone
+4408452222921
PRRC Contact
—
EUDAMED SRN
—
FDA FEI Number
—
DUNS Number
216603021

Catalogue (9)

DeviceModel / ReferenceRegistriesClassStatus
geko T-2
FDA UDI
Class IIActive
geko T-2
FDA UDI
Class IIActive
geko T-3
FDA UDI
Class IIActive
geko T-3
FDA UDI
Class IIUnknown
firefly T-2
FDA UDI
Class IIActive
geko W-3
FDA UDI
Class IIActive
geko plus R-2
FDA UDI
Class IIActive
firefly T-1
FDA UDI
Class IIActive
geko T-2 and geko Plus R-2 K180082
FDA 510(k)
Class IIActive

Related Companies

Authorised Representatives

No authorised representatives on record.

Importers

Not available yet.

Notified Bodies

Not available yet.

Authorities

Not available yet.